References of "Dogné, J.-M"
     in
Bookmark and Share    
Full Text
See detailDynamics of spontaneous ventricular fibrillation in acutely ischemic pigs
Desaive, Thomas ULg; Janssen, Nathalie ULg; Péters, F. et al

in Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology (2006), 8 (supplement 1)

Detailed reference viewed: 63 (40 ULg)
Full Text
See detailFirst and second generations of COX-2 selective inhibitors
De leval, X.; Julémont, F.; Benoit, V. et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 19 (3 ULg)
Full Text
See detailProgress in the field of GPIIb/IIIa antagonists
Hanson, Julien ULg; De Leval, X.; David, Jean-Louis ULg et al

in Current Medicinal Chemistry - Cardiovascular and Hematological Agents (2004), 2

Detailed reference viewed: 13 (0 ULg)
Full Text
See detailDesign, synthesis and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors
Julémont, F.; de Leval, X.; Michaux, C. et al

in Journal of Medicinal Chemistry (2004), 47

Detailed reference viewed: 9 (2 ULg)
Full Text
See detailIdentification of COX-2 selective inhibitor
Michaux, C.; Julémont, F.; de Leval, X. et al

in Fundamental & Clinical Pharmacology (2004)

Detailed reference viewed: 5 (1 ULg)
Full Text
See detailNew developments on thromboxane modulators
Dogné, J.-M.; Hanson, Julien ULg; de Leval, X. et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 3 (1 ULg)
Full Text
See detailRecent development in the field of dual COX / 5-LOX inhibitors
Julémont, F.; Dogné, J.-M.; Pirotte, Bernard ULg et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 4 (1 ULg)
Full Text
See detailRecent developments in 5-lipoxygenase inhibitors
Julémont, F.; Dogné, J.-M.; Laeckmann, D. et al

in Expert Opinion on Therapeutic Patents (2003), 13

Detailed reference viewed: 1 (0 ULg)
Full Text
See detailPharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation
De Leval, X.; Benoit, V.; Delarge, J. et al

in Prostaglandins, Leukotrienes, and Essential Fatty Acids (2003)

Detailed reference viewed: 6 (1 ULg)
Full Text
See detailSpectral and crystallographic study of pyridinic analogues of nimesulide : determination of the active form of methanesulfonamides as COX-2 selective inhibitors
Julémont, F.; de Leval, X.; Michaux, C. et al

in Journal of Medicinal Chemistry (2002), 45

Detailed reference viewed: 9 (4 ULg)
Full Text
See detailAdvances in the field of COX-2 inhibition
De Leval, X.; Julémont, F.; Delarge, J. et al

in Expert Opinion on Therapeutic Patents (2002), 12

Detailed reference viewed: 4 (1 ULg)
Full Text
See detailNew trends in dual 5-LOX/COX inhibition
De Leval, X.; Julémont, F.; Delarge, J. et al

in Current Medicinal Chemistry (2002), 9

Detailed reference viewed: 5 (0 ULg)
Full Text
See detailN-(3-Phenoxy-4-pyridinio)methanesulfonamidate
Michaux, C.; Charlier, C.; Julémont, F. et al

in Acta Crystallographica (2002)

Detailed reference viewed: 9 (4 ULg)
Full Text
See detailEvaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood
De Leval, X.; Delarge, J.; Devel, P. et al

in Prostaglandins, Leukotrienes, and Essential Fatty Acids (2001), 64

Detailed reference viewed: 8 (0 ULg)
See detailSynthesis and evaluation of non-carboxylic pyridinic derivatives as cyclooxygenase inhibitors
Dogne, J.-M.; De Leval, X.; Delarge, J. et al

in Mediators of Inflammation (2000), 9

Detailed reference viewed: 8 (1 ULg)
See detailProfile of nimesulide and nimesulide-L-lysine-β-cyclodextrin on chondrocyte metabolism
De Leval, X.; Dogne, J.-M.; Masereel, B. et al

in Fundamental & Clinical Pharmacology (2000), 14

Detailed reference viewed: 5 (0 ULg)
Full Text
See detailComparison of the effects of nimesulide and nimesulide-L-lysine on PGE2 production by COX-1 and COX-2 and on chondrocyte metabolism in vitro
De Leval, X.; Henrotin, Y.; Labasse, A. et al

in Pharmacy and Pharmacology Communications (2000), 6

Detailed reference viewed: 2 (2 ULg)
See detail7-Substituted alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as new analogues of diazoxide: effects on the insulin releasing process in vitro
Boverie, S.; Somers, F.; Ouedraogo, R. et al

in Fundamental & Clinical Pharmacology (2000), 14

Detailed reference viewed: 4 (2 ULg)
See detailEvaluation of classical NSAIDs on COX-1 and COX-2 purified enzymes and prognosis of their effects on physiological responses
De Leval, X.; Henrotin, Y.; Masereel, B. et al

in Fundamental & Clinical Pharmacology (2000), 14

Detailed reference viewed: 2 (0 ULg)
Full Text
See detailRecent advances in inducible cyclooxygenase (COX-2) inhibition
De Leval, X.; Delarge, J.; Somers, F. et al

in Current Medicinal Chemistry (2000), 7

Detailed reference viewed: 4 (3 ULg)